Notice: This company has been marked as potentially delisted and may not be actively trading. LogicBio Therapeutics (LOGC) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisCompetitorsEarningsInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for LogicBio Therapeutics (NASDAQ:LOGC)CurrentInstitutional OwnershipPercentage46.05%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$251.74KNumber ofInstitutional Sellers(last 12 months)0 Get LOGC Insider Trade Alerts Want to know when executives and insiders are buying or selling LogicBio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LOGC Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… LogicBio Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC46,190$252K0.0%N/A0.176% 11/4/2022 Prudential Financial Inc.98,600$27K0.0%+54.1%0.299% 4/28/2022 Harbor Capital Advisors Inc.226,731$154K0.1%-19.8%0.688% 2/15/2022 Samlyn Capital LLC1,511,417$3.49M0.0%+2.5%4.586% 2/14/2022 Eversept Partners LP291,101$672K0.0%-16.8%0.883% 2/14/2022 Blair William & Co. IL21,950$51K0.0%N/A0.067% Get the Latest News and Ratings for LOGC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LogicBio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/4/2022 Harbor Capital Advisors Inc.282,578$653K0.2%N/A0.857% 2/2/2022 Sanders Morris Harris LLC15,000$35K0.0%-57.1%0.046% 1/26/2022 Independence Bank of Kentucky12,875$30K0.0%N/A0.039% 11/16/2021 Verition Fund Management LLC113,532$520K0.0%-45.4%0.352% 11/15/2021 Pura Vida Investments LLC245,492$1.12M0.0%-1.5%0.761% 11/15/2021 Sphera Funds Management LTD.24,042$110K0.0%N/A0.075% 11/15/2021 Eversept Partners LP349,919$1.60M0.1%N/A1.085% 11/9/2021BlackRock Inc.215,736$988K0.0%-2.4%0.669% 11/9/2021 Platinum Investment Management Ltd.320,273$1.47M0.0%N/A0.993% 10/29/2021Commonwealth Equity Services LLC12,836$58K0.0%N/A0.040% 10/13/2021 Sanders Morris Harris LLC35,000$160K0.0%+133.3%0.109% 8/25/2021 Marshall Wace LLP40,568$180K0.0%N/A0.126% 8/17/2021 Walleye Capital LLC23,877$106K0.0%N/A0.074% 8/17/2021 Walleye Trading LLC12,411$55K0.0%N/A0.038% 8/17/2021 Bridgeway Capital Management LLC76,500$340K0.0%-58.2%0.237% 8/16/2021 State Street Corp24,807$110K0.0%-89.4%0.077% 8/16/2021Tibra Equities Europe Ltd76,500$340K0.1%N/A0.237% 8/16/2021 Goldman Sachs Group Inc.55,030$244K0.0%+59.0%0.171% 8/16/2021 Marshall Wace LLP40,568$180K0.0%N/A0.126% 8/13/2021 Renaissance Technologies LLC96,500$428K0.0%N/A0.299% 8/13/2021 Northern Trust Corp29,636$131K0.0%-83.3%0.092% 8/13/2021 Geode Capital Management LLC132,121$586K0.0%-42.4%0.410% 8/13/2021 Vanguard Group Inc.715,782$3.18M0.0%-10.5%2.220% 8/12/2021 Trexquant Investment LP46,229$205K0.0%+190.0%0.143% 8/12/2021 Dimensional Fund Advisors LP28,170$125K0.0%N/A0.088% 8/12/2021 JPMorgan Chase & Co.57,286$254K0.0%-76.3%0.178% 8/12/2021Ergoteles LLC66,783$297K0.0%N/A0.208% 8/11/2021 Bank of New York Mellon Corp10,930$49K0.0%-79.8%0.034% 8/11/2021 Susquehanna International Group LLP28,384$126K0.0%N/A0.088% 8/5/2021 Texas Yale Capital Corp.20,000$89K0.0%+100.0%0.062% 7/31/2021 Sanders Morris Harris LLC15,000$67K0.0%N/A0.047% 5/19/2021 Virtu Financial LLC23,721$173K0.0%N/A0.074% 5/19/2021 Squarepoint Ops LLC12,954$94K0.0%N/A0.040% 5/18/2021 Verition Fund Management LLC226,965$1.65M0.0%-1.2%0.706% The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now…5/17/2021 Samlyn Capital LLC1,399,844$10.19M0.1%-1.2%4.353% 5/17/2021 EcoR1 Capital LLC688,700$5.01M0.2%-11.1%2.141% 5/17/2021 Nuveen Asset Management LLC34,958$254K0.0%+11.7%0.109% 5/17/2021 Goldman Sachs Group Inc.34,607$252K0.0%+14.3%0.108% 5/13/2021 Trexquant Investment LP15,941$116K0.0%N/A0.050% 5/13/2021 Barclays PLC28,567$208K0.0%+41.8%0.089% 5/12/2021 Northern Trust Corp177,029$1.29M0.0%-2.8%0.550% 5/12/2021 Geode Capital Management LLC229,415$1.67M0.0%+11.8%0.713% 5/12/2021 Pura Vida Investments LLC253,102$1.84M0.1%+1.2%0.787% 5/12/2021 Texas Yale Capital Corp.10,000$73K0.0%N/A0.031% 5/12/2021 JPMorgan Chase & Co.241,799$1.76M0.0%-15.5%0.752% 5/10/2021 GSA Capital Partners LLP110,913$807K0.1%N/A0.345% 5/7/2021BlackRock Inc.984,011$7.16M0.0%+8.9%3.060% 2/25/2021 Hsbc Holdings PLC15,396$118K0.0%N/A0.048% 2/19/2021 JPMorgan Chase & Co.286,294$2.18M0.0%-6.9%0.901% 2/18/2021 Verition Fund Management LLC229,834$1.75M0.0%N/A0.723% 2/16/2021 Orbimed Advisors LLC8,466,783$64.60M0.6%+30.9%26.637% 2/16/2021 Pura Vida Investments LLC250,000$1.91M0.1%N/A0.787% 2/16/2021 Baker BROS. Advisors LP451,478$3.45M0.0%N/A1.420% 2/16/2021 Nuveen Asset Management LLC31,290$239K0.0%+5.6%0.098% 2/16/2021 Charles Schwab Investment Management Inc.34,198$261K0.0%+31.9%0.108% 2/13/2021 American International Group Inc.9,533$73K0.0%+30.7%0.030% 2/12/2021 The Manufacturers Life Insurance Company11,781$90K0.0%N/A0.037% 2/11/2021 Northern Trust Corp182,136$1.39M0.0%+34.8%0.573% 2/11/2021 Barclays PLC20,150$154K0.0%+137.2%0.063% 2/11/2021 Citigroup Inc.3,339$25K0.0%+277.3%0.011% 2/10/2021 Rhumbline Advisers13,165$100K0.0%+15.0%0.041% 2/9/2021 Wells Fargo & Company MN18,084$138K0.0%+46.0%0.057% 2/9/2021 Bank of New York Mellon Corp55,827$427K0.0%+91.2%0.176% 2/5/2021BlackRock Inc.903,727$6.90M0.0%+25.5%2.843% 2/4/2021 State of Wisconsin Investment Board22,800$174K0.0%N/A0.072% 11/6/2020BlackRock Inc.719,959$6.54M0.0%+3.1%2.346% (Data available from 1/1/2016 forward) LOGC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LOGC shares? During the previous two years, the following institutional investors and hedge funds held shares of LogicBio Therapeutics shares: Barclays PLC ($252K).Learn more on LOGC's institutional investors. What percentage of LogicBio Therapeutics stock is owned by institutional investors? 46.05% of LogicBio Therapeutics stock is owned by institutional investors. Learn more on LOGC's institutional investor holdings. Which institutional investors have been buying LogicBio Therapeutics stock? The following institutional investors have purchased LogicBio Therapeutics stock in the last 24 months: Barclays PLC ($46.19K). How much institutional buying is happening at LogicBio Therapeutics? Institutional investors have bought a total of 46,190 shares in the last 24 months. This purchase volume represents approximately $251.74K in transactions. Related Companies Beyond Major Shareholders Ethan Allen Interiors Major Shareholders Herbalife Major Shareholders MarineMax Major Shareholders Portillo's Major Shareholders SpartanNash Major Shareholders MYT Netherlands Parent B.V. Major Shareholders Almacenes Éxito Major Shareholders Build-A-Bear Workshop Major Shareholders BigCommerce Major Shareholders This page (NASDAQ:LOGC) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicBio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.